Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

  • Technology appraisal guidance
  • TA355
  • Published: 
  • Last updated: 

History

Documents created during the development process.

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: final appraisal determination

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: equality impact assessment

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: response to draft scope and provisional matrix

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: final matrix

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: final scope

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: draft scope for consultation (pre-referral) - January 2014

Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: provisional matrix (pre-referral) - January 2014